The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: a pilot randomised controlled trial with embedded process evaluation

niversity of Stirling (UK)0 个研究点目标入组 40 人开始时间: 2013年8月9日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•1. Be able to verbally communicate and write in English (English language does not have to be first language)
•2. Able to give informed consent
•3. Age of 18 or over (no upper limit)
•4. Confirmed diagnosis of Crohn's disease or Ulcerative Colitis (by clinician)
•5. Ability to do light exercise (for example to lift arms above the head or bend knees)
•6. To be able to commit to at least 6 sessions out of 8
•7. To be able to commit to do home practice of up to 45 minutes daily over the 8 weeks of the study
•8. No change of antidepressants (dose or type) within the last three months

•1. Unable to give informed consent
•2. Major psychiatric illness
•3. Active alcohol or drug dependency
•4. Scheduled for major surgery in the next three months
•5. Participation in pharmacological study or psychological intervention study within the last six months or intention to participate in pharmacological study during the duration of this study
•6. Have recently (within the last three months) been prescribed antidepressants
•7. With exacerbated symptoms

发起方

niversity of Stirling (UK)